期刊文献+

血清同型半胱氨酸与胱抑素C在2型糖尿病肾病患者中的变化意义分析 被引量:7

Analysis on clinical significance of determining serum cystatin C and homocysteine level in type 2 diabetics associated with nephropathy
下载PDF
导出
摘要 目的 在临床上对2型糖尿病合并肾病患者的血清同型半胱氨酸(Homocysteine,Hcy)水平和胱抑素C (Cystatin C,Cys C)水平进行测定,并探讨两指标在临床诊断中的价值.方法 回顾我院自选2011年6月至2013年6月间在我院进行治疗的184例糖尿病患者的病例.参照患者临床尿清白蛋白(UAER)水平分为糖尿病无肾病组(86例)和糖尿病合并肾病组(98例),并选择90例健康体检者作为对照组.对三组的Hcy、Cys C和UAER的水平进行测定和对比分析.结果 糖尿病合并肾病患者的Hcy、Cys C和UAER水平分别为(22.48±2.42)μmol/L、(2.37±0.92) mg/L和(365.41±62.85) mg/24 h显著性的大于糖尿病无肾病患者(8.13±2.01)μmol/L、(1.01±0.62) rng/L和(36.47±10.26) mg/24 h和健康对照组(7.01±1.46)μmol/L、(0.91±0.59) mg/L和(29.41±8.58) mg/24 h,(P<0.05).而糖尿病无肾病患者的Hcy、Cys C和UAER水平略大于对照组患者,但两组间差异无统计学意义(P>0.05).多元线性分析结果表明:糖尿病合并肾病患者的Hcy、Cys C和UAER成正相关性(r=0.281、0.312,P< 0.05).结论 Hcy和Cys C可作为临床诊断患者糖尿病状况的有效指标,联合使用能显著提升诊断的准确率. Objective To investigate the clinical value of determining serum cystatin C and homocysteine contents in patients with type 2 diabetes (DM2) complicated with nephropathy.Methods 184 cases of DM2 patients in our hospital from Jun 2011 to Jun 2013 were retrospectively analyzed.Based on the UAER level,patients were divided into diabetic with nephropathy group (98 cases) and diabetic without nephropathy group (86 cases).And 90 cases of healthy people were selected as control group.Results The levels of serum cystatin C,homocysteine and urine protein in diabetic with nephropathy group were (22.48 ± 2.42) μ mol/L,(2.37 ± 0.92) mg/L,(365.41 ± 62.85) mg/24 h respectively,which were significantly higher than those of diabetic without nephropathy group [(8.13 ± 2.01) μ mol/L,(1.01 ± 0.62) mg/L,(36.47 ± 10.26) mg/24 h] and control group [(7.01 ± 1.46) μ mol/L,(0.91 ± 0.59) mg/L,(29.41 ± 8.58) mg/24 h],P < 0.05.There was no significant difference in levels of serum cystatin C,homocysteine and urine protein between diabetic without nephropathy group and control group (P > 0.05).Multiple linear analysis results showed that the relationship among Hcy,Cys C and UAER was a positive correlation (r=0.281,0.312; P < 0.05).Conclusion The levels of serum cystatin C and homocysteine can be used as sensitive markers for early diagnosis of development of diabetic nephropathy.Their combined use can significantly increase the accurate rate of diagnosis.
出处 《国际医药卫生导报》 2014年第9期1285-1287,共3页 International Medicine and Health Guidance News
关键词 血清同型半耽氛酸 胱抑素C 2型糖尿病合并肾病 诊断指标 Homocysteine Serum cystatin C Type 2 diabetes Diagnostic index
  • 相关文献

参考文献11

二级参考文献29

  • 1覃文周.血清半胱氨酸蛋白酶抑制剂C检测对诊断早期肾功能损害的价值[J].广西医学院学报,2008,18(3):445-446. 被引量:17
  • 2吕旭军,茅利明,陈晓燕,吴先华,张丽霞.血清同型半胱氨酸与糖尿病及糖尿病肾病[J].江西医学检验,2006,24(1):78-79. 被引量:18
  • 3金秀平,杨春伟,王浩.早期糖尿病肾病相关诊断指标探讨[J].检验医学与临床,2007,4(4):248-250. 被引量:19
  • 4[1]李保春,王林辉,梅小斌,等.糖尿病肾病[M].上海:第二军医大学出版社,2005.24. 被引量:1
  • 5[3]Torffvit O,Rippe B.Size and charge selectivity of the glomerular filter in patients with insulin-dependent diabetic mellitus:urinary immnuoglobulins and glycosaminoglycans[J].Nephron,1999,83(4):301-307. 被引量:1
  • 6[4]蔡锡麟,陈耀华,秦明秀.临床放射免役学[M].北京:北京原子能出版社,1994.199. 被引量:1
  • 7de Mutsert R,Snijder MB,van der Sman-de Beer F,et al.Association between body mass index and mortality issimilar in the hemodialysis population and the generalpopulation at high age and equal duration of follow-up[J].J Am Soc Nephrol,2007,18(3):967-974. 被引量:1
  • 8Ozkan Y,Ozkan E,Simsek B.Plasma total homocysteineand cysteine levels as cardiovascular risk factors in coro-nary heart disease[J].Int J Cardiol,2002,82(3):269-277. 被引量:1
  • 9Senn JJ,Klover PJ,Nowak IA,et al.Interleukin-6inducescellular insulin resistance in hepatocytes[J].Diabetes,2002,51(12):3391-3399. 被引量:1
  • 10Ban Cr,Twigg SM.Fibrosis in diabetes complications:pathogenic mechanisms and circulating and urinarymarkers[J].Vasc Health Risk Manag,2008,4(3):575-596. 被引量:1

共引文献138

同被引文献44

  • 1王诚,何伶俐,胡新梅,王世君,余红岚.血清同型半胱氨酸和血清胱抑素C及尿β_2-微球蛋白联合检测对糖尿病肾病的临床价值[J].中国老年学杂志,2014,34(6):1509-1510. 被引量:13
  • 2李吉河,吴曼,娄岩,刘树军,苗里宁.生化检查及尿蛋白五项检查在诊断老年早期糖尿病肾病中的意义[J].中国老年学杂志,2014,34(7):1766-1767. 被引量:14
  • 3Lee SD, Kim SH, Kong SY, et al. Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab[J].Transpl Immunol, 2015, 32 (1) : 29-34. 被引量:1
  • 4Umemura A, Nitta H, Sasaki A, et al. ABO-Incompatible Living Donor Liver Transplantation from Hepatitis B Core Antibody Positive Donor to Hepatitis C Liver Cirrhosis Recipient: A Case Report [J].Case Rep Transplant, 2014: 507621. 被引量:1
  • 5Kheradmand T, Anthony TL, Harland RC, et al. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature HI.Hum Immunol, 2014, 75 ( 6 ) : 578-583. 被引量:1
  • 6Nakamura Y, Hama K, Iwamoto H, et al. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis : a case report[J]. Transplant Proe, 2012, 44 (2) : 565-569. 被引量:1
  • 7Ushigome H, Koshino K, Sakai K, et al. Rare spontaneous remission of hepatic artery aneurysm following ABO incompatible living donor liver transplantation: a ease report[J].Transplant Proe, 2011, 43 (6) : 2424-2427. 被引量:1
  • 8YamadaY, HoshinoK, ShimojimaN, etal. Idiopathichypereosinophilic syndrome in a case with ABO-incompatible liver transplantation for biliary atresia complicated by portal vein thrombosis[J]. Pediatr Transplant, 2010, 14 (5) : e49-53. 被引量:1
  • 9Looker HC,Fagot-Campagna A,Gunter EW,et al.Homocysteineand vitamin B12 concentrations and mortality rates in type 2 diabetes. Diabetes Metab Res Rev,2007,23(3):193-201. 被引量:1
  • 10Li,K.,Yu,L.,Liu,X,et al.A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel[J].Biomaterials,2013,34(11):2834-2842. 被引量:1

引证文献7

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部